Fortrea Holdings Inc. (FTRE) — SEC Filings
Fortrea Holdings Inc. (FTRE) — 40 SEC filings. Latest: 8-K (May 5, 2026). Includes 19 8-K, 5 10-Q, 3 8-K/A.
View Fortrea Holdings Inc. on SEC EDGAR
Overview
Fortrea Holdings Inc. (FTRE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Apr 27, 2026: Fortrea Holdings Inc. filed a DEFA14A on April 27, 2026, related to additional definitive proxy soliciting materials. The filing includes three documents: the main DEFA14A filing, and two graphic files. The company's mailing and business address is 8 Moore Drive, Durham, NC 27709.
Sentiment Summary
Across 40 filings, the sentiment breakdown is: 1 bearish, 39 neutral. The dominant filing sentiment for Fortrea Holdings Inc. is neutral.
Filing Type Overview
Fortrea Holdings Inc. (FTRE) has filed 19 8-K, 1 ARS, 2 DEFA14A, 5 10-Q, 3 8-K/A, 2 DEF 14A, 2 10-K, 3 SC 13G, 2 SC 13D/A, 1 SC 13G/A with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (40)
Risk Profile
Risk Assessment: Of FTRE's 31 recent filings, 1 were flagged as high-risk, 17 as medium-risk, and 13 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $2,062.9M |
| Net Income | $ -953.7M |
| EPS | $ -10.53 |
| Debt-to-Equity | 3.72 |
| Cash Position | $131.3M |
| Operating Margin | -41.6% |
| Total Assets | $2,742.1M |
| Total Debt | $1,126.6M |
Key Executives
- Dr. David M. E. Chew
- Jeffrey C. Smith
- Andrew Freedman
- Meagan Reda
- Michael A. Zito
- Michael A. D'Amelio
- David M. Dvorak
- Robert L. King
Industry Context
Fortrea operates in the Contract Research Organization (CRO) industry, which provides essential services to pharmaceutical and biotechnology companies for drug development. The industry is highly competitive, driven by R&D spending, regulatory landscapes, and the need for specialized expertise. Trends include increasing demand for decentralized clinical trials, advanced data analytics, and personalized medicine, requiring significant investment in technology and talent.
Top Tags
compensation (6) · governance (6) · management-change (5) · financials (5) · amendment (5) · executive-compensation (4) · 10-Q (4) · financial-reporting (3) · corporate-actions (3) · material-agreement (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss (9 months ended Sep 30, 2025) | $953.7M | Significantly widened from $267.3M in 2024, primarily due to impairment. |
| Goodwill and Other Asset Impairments (9 months ended Sep 30, 2025) | $797.9M | Major charge impacting profitability, up from $24.0M in 2024. |
| Revenues (3 months ended Sep 30, 2025) | $701.3M | Increased from $674.9M in the prior year quarter. |
| Revenues (9 months ended Sep 30, 2025) | $2,062.9M | Increased from $1,999.4M in the prior year period. |
| Net Cash Used for Operating Activities (9 months ended Sep 30, 2025) | $15.6M | Reversed from $245.7M provided in the prior year, indicating operational cash burn. |
| Total Assets (Sep 30, 2025) | $2,742.1M | Decreased from $3,579.2M at Dec 31, 2024, largely due to goodwill reduction. |
| Cash and Cash Equivalents (Sep 30, 2025) | $131.3M | Increased from $118.5M at Dec 31, 2024. |
| Shares Outstanding (Nov 3, 2025) | 92.4M | Reflects common stock outstanding. |
| SEC File Number | 001-41704 | Identifies the specific filing for Fortrea Holdings Inc. |
| EIN | 92-2796441 | Employer Identification Number for Fortrea Holdings Inc. |
| Commission File Number | 001-41704 | Identifies the company's SEC filing record |
| I.R.S. Employer Identification No. | 92-2796441 | Company's tax identification number |
| Filing Date | 20250428 | Date the DEF 14A was filed. |
| Period of Report | 20250610 | The period this filing pertains to. |
| Fiscal Year End | 1231 | Fortrea Holdings Inc.'s fiscal year ends on December 31st. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Fortrea Holdings Inc. (FTRE)?
Fortrea Holdings Inc. has 40 recent SEC filings from Jan 2024 to May 2026, including 19 8-K, 5 10-Q, 3 8-K/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of FTRE filings?
Across 40 filings, the sentiment breakdown is: 1 bearish, 39 neutral. The dominant sentiment is neutral.
Where can I find Fortrea Holdings Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Fortrea Holdings Inc. (FTRE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Fortrea Holdings Inc.?
Key financial highlights from Fortrea Holdings Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for FTRE?
The investment thesis for FTRE includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Fortrea Holdings Inc.?
Key executives identified across Fortrea Holdings Inc.'s filings include Dr. David M. E. Chew, Jeffrey C. Smith, Andrew Freedman, Meagan Reda, Michael A. Zito and 3 others.
What are the main risk factors for Fortrea Holdings Inc. stock?
Of FTRE's 31 assessed filings, 1 were flagged high-risk, 17 medium-risk, and 13 low-risk.
What are recent predictions and forward guidance from Fortrea Holdings Inc.?
Forward guidance and predictions for Fortrea Holdings Inc. are extracted from SEC filings as they are enriched.